Photobiomodulation
DeviceApplication of light at specific wavelength for interaction with biological tissue
NCT Number: NCT04281446
Hormonal fluctuations present during the ovarian cycle may have a strong influence on physiological and psychological aspects on physical performance in women. The aspects surrounding performance and ovarian cycles in women during different phases of the cycle, are still current and should be debated in the literature, as the available evidence has conflicting results. In addition to the above, new ergogenic methods have been studied to improve the sports scenario in different populations. Research on the use of ergogenic electrophysical resources so that hormonal effects may possibly be mitigated, allowing women to use this resource and improving their physical performance is still scarce in the current literature.
Looking for future studies?
Notify Me18 year–35 year
Female
Interventional
Not applicable
Rinaldo Roberto de Jesus Guirro, Ribeirão Preto, São Paulo, Brazil
Objective: To evaluate the physical performance of women during different phases of the ovarian cycle and the influence of photobiomodulation therapy in this setting. Methods: The research will be conducted in two subprojects - Subproject I is a cross-sectional study. Initially the participants will be evaluated in two phases separately, being the first and second day within the ovarian cycle in the follicular phase (FF) and the third and fourth day in the luteal phase (FL). The aspects of body composition, body water volume and skin temperature by infrared thermography will be evaluated, and the physical performance evaluation will be constituted by the evaluation of the muscular performance by isokinetic dynamometer, and by a treadmill supramaximal effort test. , together with analysis of VO2max and blood lactate levels. Subproject II is a double-blind placebo-controlled randomized clinical trial. After completion of subproject I, during the next ovarian cycle within the participants will return to conduct the second part of the study, which will analyze the influence of photobiomodulation therapy on the physical performance of women within their menstrual cycle, related to low hormone rate ( FF). 200 J of energy will be applied before each evaluation, which is muscle performance and endurance. The tests will be performed in the same order, following the same protocol in both phases of the study. For data analysis, a normality test will be used to verify the distribution and statistical tests consistent with the appropriate intra and intergroup comparisons, being considered two factors in the comparisons, time and group. A significance level of 5% will be adopted. The effect size will be calculated by Cohens'd.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Application of light at specific wavelength for interaction with biological tissue
Time frame: 20 minutes
Distance traveled during incremental testing (km)
Time frame: 20 minutes
Quantitative assessment of muscle performance performed by isokinetic dynamometer (N/m; W, %)
Time frame: 20 minutes
Modified 10-point Borg scale
The scale assesses the level of effort, with 0 being no effort and 10 being the maximum physical effort.
Time frame: 20 minutes
VO2máx (ml.kg-1.min-1)
Time frame: 20 minutes
Lactate threshold (iLL) and anaerobic threshold (iLAN) (mmol/L)
Time frame: 15 minutes
Thermographic evaluation (°C)
Time frame: 10 minutes
Bioimpedance Evaluation (%)
University of Sao Paulo
Other
Mapping the Physical Performance of Women From Endogenous Ovarian Cycles at Different Stages of the Menstrual Cycle, and the Respective Influence of Photobiomodulation Therapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07286136
Hormonal Imbalance, Menstrual Cycle Disorder
Las Vegas, Nevada, United States
View Trial DetailsNCT06585475
Anxiety Disorders, Behavior
Sakarya, Turkey (Türkiye)
View Trial DetailsNCT04806815
COVID-19, Coronaviridae Infections
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT02804594
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
San Francisco, California, United States
View Trial Details